What is Aldeyra Therapeutics, Inc. (ALDX)?
Aldeyra Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for immune-mediated and inflammatory diseases. The company utilizes aldehyde trapping technology to design small molecule drugs that modulate oxidative stress and inflammation pathways. Aldeyra's product candidates target conditions such as ocular diseases, autoimmune disorders, and rare inflammatory conditions. The company conducts clinical trials to assess the safety and therapeutic potential of its compounds. Aldeyra Therapeutics collaborates with academic and industry partners to support its research and development efforts. It emphasizes a science-driven approach to drug discovery and development. The company operates research facilities dedicated to medicinal chemistry, pharmacology, and clinical development. Its objective is to provide innovative treatment options for patients with inflammatory diseases.
Aldeyra Therapeutics, Inc. Stock Price Today: Live Overview
The price today is shaped by present trading activity as Aldeyra Therapeutics, Inc. is priced at $1.89. The daily price has fluctuated from $1.72 up to $1.98, resulting in a change of -1.6216%.
FAQ: Aldeyra Therapeutics, Inc. (ALDX)
What is the current price of ALDX stock?
Aldeyra Therapeutics, Inc.'s current price is $1.89.
Does ALDX pay dividends?
Aldeyra Therapeutics, Inc. does not pay dividends.
Does ALDX have a formal corporate presence or regional headquarters in the UAE?
Aldeyra Therapeutics, Inc. has no official UAE presence and operates through distributors.
What is ALDX best known for?
Aldeyra Therapeutics, Inc. is most famous for developing treatments for inflammatory and fibrotic diseases.
What assets are typically shown together with ALDX?
Commonly shown alongside ALDX: Schwab Fundamental International Equity ETF, YieldMax DIS Option Income Strategy ETF, SoftBank Group Corp.
Latest shares articles



